Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSThe cullin 4 RING ligase (CRL4) complex is an E3 ubiquitin ligase complex.1,2,3 It is composed of the substrate receptor cereblon (CRBN), DNA damage-binding protein 1 (DDB1), cullin 4A or 4B, and RING box protein 1 (RBX1). CRBN interacts with DDB1 via its helical bundle between the Lon protease-like domain and thalidomide-binding domain. The CRL4 complex targets substrates for proteasomal degradation by ubiquitination and is involved in regulation of the cell cycle, embryogenesis, DNA repair, replication, transcription, and carcinogenesis.2 Mutations in CRBN are associated with autosomal recessive non-syndromic intellectual disability, and CRBN is also the target of thalidomide-induced teratogenicity.2,3,4 Mutations in DDB1 are also associated with intellectual disability, as well as obesity, digital anomalies, hypotonia, and malformations.5 Cayman’s CRBN/DDB1 Complex (human, recombinant) protein can be used for enzyme activity assay and binding assay applications.
WARNING This product is not for human or veterinary use.
1. Function and regulation of cullin-
2. Cereblon in health and disease. Pflugers Arch. 468(8), 1299-1309 (2016).
3. Cereblon: Promise and challenges for combating human diseases. Pflugers Arch. 473(11), 1695-1711 (2021).
4. Identification of a primary target of thalidomide teratogenicity. Science 327(5971), 1345-1350 (2010).
5. A DNA repair disorder caused by de novo monoallelic DDB1 variants is associated with a neurodevelopmental syndrome. Am. J. Hum. Genet. 108(4), 749-756 (2021).